SABCS15 Wedesday Press Conference
Dec 09, 2015•1 hr 3 min
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
Moderator: SABCS Co-director Virginia Kaklamani, MD, leader of the Breast Cancer Program at the Cancer Therapy & Research Center and professor of medicine at the UT Health Science Center San Antonio
- Capecitabine Improved Outcomes for Breast Cancer Patients With Residual Disease After Presurgery Chemotherapy;
- Women With Luminal A Subtype of Breast Cancer Did Not Benefit From Adjuvant Chemotherapy;
- Denosumab Improves Disease-free Survival for Postmenopausal Patients With HR-positive Breast Cancer; and
- Pathologic Complete Response to Presurgery Chemotherapy Improves Survival For Patients With Triple-negative Breast Cancer.
For the best experience, listen in Metacast app for iOS or Android